| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |